PB1795: MESENCHYMAL STROMAL CELL-DEPENDENT ADHESION PATHWAYS PROTECT AML CELLS FROM VENETOCLAX-INDUCED APOPTOSIS
Main Authors: | Marilena Ciciarello, Giulia Rosaci, Giulia Corradi, Samantha Bruno, Jacopo Nanni, Michele Cavo, Antonio Curti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000974036.37075.c8 |
Similar Items
-
Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?
by: Marilena Ciciarello, et al.
Published: (2021-10-01) -
P1375: VENETOCLAX MODULATES TIM-3 EXPRESSION ON CD8 T CELLS IN ACUTE MYELOID LEUKEMIA PATIENTS
by: Darina Ocadlikova, et al.
Published: (2023-08-01) -
PB2413: SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
by: Inna Shaforostova, et al.
Published: (2023-08-01) -
Review of Venetoclax in CLL, AML and Multiple Myeloma
by: Masa Lasica, et al.
Published: (2021-05-01) -
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
by: Chiara Tomasoni, et al.
Published: (2023-12-01)